Treatment of hepatoma with liposome-encapsulated adriamycin administered into hepatic artery of rats

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 29

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

315

HTML

1885

Figures (1-1)

218

Tables (1-4)

179

Sum=2597

Aug 7, 2006 (publication date) through Nov 12, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Aug 7, 2006; 12(29): 4741-4744
Published online Aug 7, 2006. doi: 10.3748/wjg.v12.i29.4741

Table 4 Mean survival time and increased life span after treatment (mean ± SD)

% ILS : Increased life span.

^aP < 0.05 vs FADM, ADM + BL;

^bP < 0.01 vs NS.

Citation: Sun DS, Chen JH, Ling R, Yao Q, Wang L, Ma Z, Li Y. Treatment of hepatoma with liposome-encapsulated adriamycin administered into hepatic artery of rats. World J Gastroenterol 2006; 12(29): 4741-4744
URL: https://www.wjgnet.com/1007-9327/full/v12/i29/4741.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i29.4741